<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Eleven separate three-month courses of <z:chebi fb="0" ids="4031">cyclosporin A</z:chebi>, an oral solution 10 mg/kg/day, were administered to eight patients with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease with sight-threatening <z:hpo ids='HP_0012123'>posterior uveitis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>It was found to be effective in arresting the inflammatory activity in the eye as well as the mucocutaneous lesions of <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease </plain></SENT>
<SENT sid="2" pm="."><plain>Improvement in visual acuity was observed within one week of starting therapy </plain></SENT>
<SENT sid="3" pm="."><plain>Severe exacerbations in the ocular and mucocutaneous lesions occurred on withdrawal of the drug </plain></SENT>
<SENT sid="4" pm="."><plain>At this dosage side effects included <z:hpo ids='HP_0001007'>hirsutism</z:hpo> in <z:hpo ids='HP_0000001'>all</z:hpo> women, and a slight rise of serum <z:chebi fb="0" ids="16990">bilirubins</z:chebi> in two patients and of blood <z:chebi fb="20" ids="16199">urea</z:chebi> in one patient </plain></SENT>
<SENT sid="5" pm="."><plain>The latter two conditions responded rapidly to dose adjustment </plain></SENT>
</text></document>